SteadySense - investment platform Startup.Network

Idea or High Level Concept

Our smart sensor is embedded in a body patch and it continuously measures the human body temperature. Applications for this sensor patches are ovulation detection (see https://www.femsense.com) or general temperature measurement (see https://www.steadytemp.info)

Territory of the product or service implementation

Global (world)

Traction and Current Status

Our first product, femSense, gained massive traction in central Europe, achieving over €300k in sales last year (2020) and helping over 10k women get pregnant.

Problem or Opportunity

Beside the support for getting pregnant - 15% of all women have difficulty to get pregnant - there is a strong trend to understand the menstruation cycle and the fertility to use the knowledge as a hormone free method of birth control. femSense is an easy to use and reliable system to display the fertility of a woman.

The second product, SteadyTemp, displays the body temperature curve on a mobile device. The shape and the trend of the fever curve has much more value for doctors who can draw conclusions for their diagnose much better than from a single temperature value.

Solution

Sensor Patch:
Fully integrated temperature sensor embedded in a body patch
Exclusive rights on the sensor chip, 2 patents pending

femSense:
Sensor patch used to detect the ovulation of a woman
Mobile app to guide the user through the cycle and displays fertile and non-fertile days
medical device class 1, CE marked, FDA clearance
certification as contraceptive (MD class 2b) planned for 2022
registered brand name

SteadyTemp:
Identical sensor patch with slightly different software as femSense
Mobile app to guide the user and displays body temperature curve
medical device class 1m, CE marked, certified by notified body

Customer Segments and Market

femSense:
ww SAM for planning a pregnancy: 2 b€
ww SAM for fertility awareness: 12 b€
ww TAM for contraception: >160 b€

SteadyTemp
ww SAM high income countries: 2 b€

Revenue Streams and Cost Structure

Revenue plan:
2020: 0,3 M€
2021: 1,0 M€
2022: 4,0 M€

Business Model, Chanells, Metrics

We sell the sensor patches either directly to the end customer (in case of femSense) or to institutions or partners (in case of SteadyTemp). The required mobile app is free of charge

Competitors and Existing Alternatives

femSense competitors:
- Mobile calendar apps like flo, Glow, Natural Cycles, ...
- Invasive temperature systems like OvulaRing, Trackle, OvuSense, ...-
- Hormone measurement systems like Clearblue, ...
- Others like AVA, Yono Labs, iweecare, ...

SteadyTemp competitors:
- conventional thermometers with electronic interface
- continuous temperature systems like iweecare, Fever Scout, TempTRAQ, ...
- invasive thermometers, like bladder catheter

Advantages or differentiators

Advantage ...
Compared to cycle tracker apps:
- Higher reliability due to continuous measurement
- Revenue made with patches rather than data (privacy, no commercials)

Compared to invasive systems:
- Comfortable and easy to use
- Price

Compared to hormone-based systems:
- Continuous measurement
- High comfort and easy to use

Compared to other continuous temperature systems
- NFC interface ensures data privacy
- single use patches ensure high hygienic standard

Risks

femSense risks:
- little risk for planning pregnancy or fertility awareness beside CAC could become too high
- for contraceptive the required clinical study could take longer as planned (later market launch)

SteadyTemp risks:
- long design-in cycles in hospital or care center applications